To assess the effect of downregulating PSMB10 on AML progression in vivo, we employed an AML xenograft model with NOD/ShiLtJGpt-Prkdcem26Cd52Il2rgem26Cd22/Gpt (NCG) mice (Fig. 3A). The gene discussed is PSMB10; the disease is acute myeloid leukemia.